Has mortality of community-acquired pneumonia really reduced?

Pedro Puerta-Alcalde, Celia Cardozo-Espinola, Catia Cilloniz, Antoni Torres, Carolina Garcia-Vidal

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

1 Cita (Scopus)


Community-acquired pneumonia is a major health problem associated with high morbidity and mortality, and hospital admissions for pneumonia seem to be increasing. Whether mortality is currently decreasing is controversial and is influenced by several factors: aging population and increase in comorbidities, microbiological and antibiotic changes, management improvements in intensive care units, pneumococcal and influenza vaccines, and immunomodulatory treatments. Despite the heterogeneity of data, in the last few years, some important articles have been published, suggesting a progressive decline in mortality despite an upward trend in patient age and comorbidities. However, increasing efforts are needed for a more significant improvement in the prognosis of these patients. For example, enhanced adherence to guidelines and a more rigorous sepsis management, as well as improvement in vaccine results are required. Moreover, new and improved diagnostic tests and antibiotic regimens will probably be required, just like better identification of patients who may benefit from immunomodulatory therapy.

Idioma originalInglés estadounidense
Páginas (desde-hasta)258-262
PublicaciónClinical Pulmonary Medicine
EstadoIndizado - 2017
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc.


Profundice en los temas de investigación de 'Has mortality of community-acquired pneumonia really reduced?'. En conjunto forman una huella única.

Citar esto